An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Investigational Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to message these profiles directly for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.
Several experts said the demand for the experimental drug could be linked to the increasing price of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.
Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.
Service Response and Content Elimination
According to TikTok, the platform has taken down violative content and banned related keywords and query recommendations. The organization stated it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Research also found communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.
Within minutes of joining one community, a vendor posted contact information, where the majority of transactions occur. The vendor sent an guidebook and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.
Item Information and Pricing
Inside these communities, posts show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how long a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.
Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may subject patients to possibly significant medical dangers”.
